KIRANJOT GUJRAL, M.D
Endocrinology, Diabetes & Metabolism Physician in CLERMONT, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
KIRANJOT GUJRAL, M.D reported a CMS MIPS final score of 98.0699/100 — above the 83.1 national average — and filed 591 Medicare Part D claims in 2023.
- 98.0699/100
- MIPS score · +15 vs avg
- 591
- Part D claims, 2023
- 58%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
KIRANJOT GUJRAL, M.D's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
98 Top 11% higher than 89% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
KIRANJOT GUJRAL, M.D practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about KIRANJOT GUJRAL, M.D?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Florida
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers
Endocrinology, Diabetes & Metabolism Physician share within Florida
Endocrinology, Diabetes & Metabolism Physician is one of the more visible NUCC categories in Florida
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
KIRANJOT GUJRAL, M.D's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average
- MIPS Final Score
- 98.0699/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 98.0699/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Endocrinology, Diabetes & Metabolism Physician US NPIs
98.0699/100 MIPS final score — 15.0 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Endocrinology, Diabetes & Metabolism Physician. Quality dim: 86.1398.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
KIRANJOT GUJRAL, M.D appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.D credentials at 1970 HOSPITAL VIEW WAY UNIT B, CLERMONT, FL, 34711, with a listed phone of (352) 677-9141. NPI 1124344122 was issued on 04/15/2010. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GUJRAL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 591 prescription claims written by this provider, covering 169 Medicare beneficiaries and totaling roughly $380K in drug spend, split 42% brand-name and 58% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 98.0699/100 for the 2023 performance year (Quality 86.1398), compared with the national average of 83.1.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1124344122 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | M.D |
| Gender | Female |
| NPI Issued | 04/15/2010 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm KIRANJOT GUJRAL, M.D's current license status, disciplinary history, and board certifications with the Florida Board of Medicine in Florida before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
License & disciplinary context — Florida FLDOH 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to KIRANJOT GUJRAL, M.D. To verify KIRANJOT GUJRAL, M.D's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
42% brand-name claims vs 58% generic, on 591 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,433
- Total Day Supply
- 42,521
- Brand vs Generic
- 42% brand / 58% generic
- Brand Drug Cost
- $355K
- Generic Drug Cost
- $10K
Patient Demographics
- Average Patient Age
- 68.4 years
- Avg HCC Risk Score
- 1.73
- Gender Split
- 61% female / 39% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What KIRANJOT GUJRAL, M.D prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
110 claims
- Alendronate Sodium 37
Alendronate Sodium
37 claims
- Jardiance 34
Jardiance
34 claims
- Novolog Flexpen 23
Novolog Flexpen
23 claims
- Metformin Hcl Er 20
Metformin Hcl Er
20 claims
- Methimazole 19
Methimazole
19 claims
- Hydrocortisone 17
Hydrocortisone
17 claims
- Ozempic 17
Ozempic
17 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 110 |
| Alendronate Sodium | 37 |
| Jardiance Empagliflozin | 34 |
| Novolog Flexpen Insulin Aspart | 23 |
| Metformin Hcl Er Metformin Hcl | 20 |
| Methimazole | 19 |
| Hydrocortisone | 17 |
| Ozempic Semaglutide | 17 |
| Prednisone | 16 |
| Metformin Hcl | 15 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Endocrinology, Diabetes & Metabolism Physician Overview
How KIRANJOT GUJRAL, M.D fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
KIRANJOT GUJRAL, M.D's 591 claims are below the specialty average of 2,639.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as GUJRAL.
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Florida
Frequently Asked Questions
What is KIRANJOT GUJRAL, M.D's specialty? ▼
How much does KIRANJOT GUJRAL, M.D prescribe under Medicare Part D? ▼
What is KIRANJOT GUJRAL, M.D's Medicare quality score? ▼
Where is KIRANJOT GUJRAL, M.D located? ▼
What is KIRANJOT GUJRAL, M.D's NPI number? ▼
Does KIRANJOT GUJRAL, M.D prescribe more brand-name or generic drugs? ▼
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
What drugs does KIRANJOT GUJRAL, M.D prescribe most often? ▼
Does KIRANJOT GUJRAL, M.D accept Medicare? ▼
How can I verify KIRANJOT GUJRAL, M.D's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology